|
業務類別
|
Biotechnology |
|
業務概覽
|
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic. |
| 公司地址
| 7 Times Square, 43rd Floor, New York, NY, USA, 10036 |
| 電話號碼
| +1 929 999-4055 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.dianthustx.com |
| 員工數量
| 92 |
| Mr. Marino Garcia |
President, Chief Executive Officer and Director |
美元 630.00K |
09/04/2026 |
| Dr. Simrat Randhawa, M.D. |
Executive Vice President and Head, Research and Development |
美元 530.56K |
09/04/2026 |
| Mr. Adam M. Veness, Esq. |
Senior Vice President, General Counsel and Secretary |
-- |
09/04/2026 |
| Mr. Edward G. Carr |
Senior Vice President and Chief Accounting Officer |
-- |
09/04/2026 |
| Mr. Ryan Savitz |
Executive Vice President, Chief Financial Officer, Chief Business Officer and Treasurer |
美元 482.56K |
09/04/2026 |
|
|
| Dr. Simon Read, PhD |
Independent Director |
09/04/2026 |
| Dr. Steven Joseph Romano, M.D. |
Independent Director |
09/04/2026 |
| Ms. Alison F. Lawton |
Chairman of the Board |
09/04/2026 |
| Ms. Anne M. McGeorge |
Independent Director |
09/04/2026 |
| Mr. Marino Garcia |
President, Chief Executive Officer and Director |
09/04/2026 |
| Mr. Sujay R. Kango |
Independent Director |
09/04/2026 |
| Ms. Paula Soteropoulos |
Independent Director |
09/04/2026 |
| Dr. Jonathan Violin, M.B.A.,PhD |
Independent Director |
09/04/2026 |
|
|
|
|
